These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 9434288)
21. Self dispersing mixed micelles forming systems for enhanced dissolution and intestinal permeability of hydrochlorothiazide. Sultan AA; El-Gizawy SA; Osman MA; El Maghraby GM Colloids Surf B Biointerfaces; 2017 Jan; 149():206-216. PubMed ID: 27768910 [TBL] [Abstract][Full Text] [Related]
22. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation. Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353 [TBL] [Abstract][Full Text] [Related]
23. Lipidic dispersion to reduce food dependent oral bioavailability of fenofibrate: In vitro, in vivo and in silico assessments. O'Shea JP; Faisal W; Ruane-O'Hora T; Devine KJ; Kostewicz ES; O'Driscoll CM; Griffin BT Eur J Pharm Biopharm; 2015 Oct; 96():207-16. PubMed ID: 26215636 [TBL] [Abstract][Full Text] [Related]
24. Development and in vivo evaluation of an innovative "Hydrochlorothiazide-in Cyclodextrins-in Solid Lipid Nanoparticles" formulation with sustained release and enhanced oral bioavailability for potential hypertension treatment in pediatrics. Cirri M; Mennini N; Maestrelli F; Mura P; Ghelardini C; Di Cesare Mannelli L Int J Pharm; 2017 Apr; 521(1-2):73-83. PubMed ID: 28229944 [TBL] [Abstract][Full Text] [Related]
25. Preparation and In Vitro-In Vivo Evaluation of Sustained-Release Matrix Pellets of Capsaicin to Enhance the Oral Bioavailability. Zhang Y; Huang Z; Omari-Siaw E; Lu S; Zhu Y; Jiang D; Wang M; Yu J; Xu X; Zhang W AAPS PharmSciTech; 2016 Apr; 17(2):339-49. PubMed ID: 26127010 [TBL] [Abstract][Full Text] [Related]
26. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability. Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445 [TBL] [Abstract][Full Text] [Related]
27. Solid lipid extrusion with small die diameters--electrostatic charging, taste masking and continuous production. Witzleb R; Kanikanti VR; Hamann HJ; Kleinebudde P Eur J Pharm Biopharm; 2011 Jan; 77(1):170-7. PubMed ID: 20940049 [TBL] [Abstract][Full Text] [Related]
28. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type. Thommes M; Kleinebudde P Eur J Pharm Biopharm; 2006 May; 63(1):68-75. PubMed ID: 16325384 [TBL] [Abstract][Full Text] [Related]
29. Preparation of pH-dependent modified-release pellets of urapidil to improve its bioavailability. He H; Li H; Tang X Pharm Dev Technol; 2011 Jun; 16(3):212-8. PubMed ID: 20151942 [TBL] [Abstract][Full Text] [Related]
30. In vitro/in vivo evaluation of hydrochlorothiazide in experimental hydrochlorothiazide/triamterene combination tablets in beagle dogs. Ritschel WA; Turkoglu M; Lipps D; Warner A; Sakr A Arzneimittelforschung; 1991 Mar; 41(3):208-11. PubMed ID: 1867656 [TBL] [Abstract][Full Text] [Related]
31. Comparative bioavailability of two immediate-release tablets of lisinopril/hydrochlorothiazide in healthy volunteers. Gascón AR; Cuadrado A; Solinís MA; Hernández RM; Ramírez E; Dalmau R; Pedraz JL Int J Clin Pharmacol Ther; 2003 Jul; 41(7):309-15. PubMed ID: 12875347 [TBL] [Abstract][Full Text] [Related]
32. A comparative study between hot-melt extrusion and spray-drying for the manufacture of anti-hypertension compatible monolithic fixed-dose combination products. Kelleher JF; Gilvary GC; Madi AM; Jones DS; Li S; Tian Y; Almajaan A; Senta-Loys Z; Andrews GP; Healy AM Int J Pharm; 2018 Jul; 545(1-2):183-196. PubMed ID: 29730176 [TBL] [Abstract][Full Text] [Related]
33. Chitosan-kaolin coprecipitate as disintegrant in microcrystalline cellulose-based pellets elaborated by extrusion-spheronization. Goyanes A; Souto C; Martínez-Pacheco R Pharm Dev Technol; 2013 Feb; 18(1):137-45. PubMed ID: 22309024 [TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo availability of spironolactone from oral dosage forms. Chao AY; Sanvordeker DR; Zagarella J; Mattes K; Nicholova B; Karim A J Pharm Sci; 1976 Nov; 65(11):1630-4. PubMed ID: 993995 [TBL] [Abstract][Full Text] [Related]
35. Characterization and Pharmacokinetic Study of Aprepitant Solid Dispersions with Soluplus®. Liu J; Zou M; Piao H; Liu Y; Tang B; Gao Y; Ma N; Cheng G Molecules; 2015 Jun; 20(6):11345-56. PubMed ID: 26102068 [TBL] [Abstract][Full Text] [Related]
36. Improvement of dissolution and bioavailability for mebendazole, an agent for human echinococcosis, by preparing solid dispersion with polyethylene glycol. Chiba Y; Kohri N; Iseki K; Miyazaki K Chem Pharm Bull (Tokyo); 1991 Aug; 39(8):2158-60. PubMed ID: 1797442 [TBL] [Abstract][Full Text] [Related]
38. Dissolution and bioavailability enhancement of alpha-asarone by solid dispersions via oral administration. Deng L; Wang Y; Gong T; Sun X; Zhang ZR Drug Dev Ind Pharm; 2017 Nov; 43(11):1817-1826. PubMed ID: 28665158 [TBL] [Abstract][Full Text] [Related]
39. Facile formation of co-amorphous atenolol and hydrochlorothiazide mixtures via cryogenic-milling: Enhanced physical stability, dissolution and pharmacokinetic profile. Moinuddin SM; Ruan S; Huang Y; Gao Q; Shi Q; Cai B; Cai T Int J Pharm; 2017 Oct; 532(1):393-400. PubMed ID: 28893583 [TBL] [Abstract][Full Text] [Related]